KKR · Q3 2025 Earnings
BullishKKR & Co.
Reported November 7, 2025
30-second summary
KKR printed $1.41 of after-tax adjusted EPS, $1.03B of fee-related earnings, and $43B of new capital raised in Q3, with insurance operating earnings of $305M beating the $250M+/quarter run-rate guide by $55M. The bigger signal is management's framing shift: 2026 targets of $4.50+ FRE/share and $7.80+ ANI/share were reaffirmed with explicit confidence rather than hedged, and the insurance line was reframed from a standalone earnings contributor to a multi-segment economics engine generating $1.8B LTM, with another $200M of accrued income sitting off P&L until 2027–2028.
Headline numbers
EPS
Q3 FY2025
$1.41
Key financials
Q3 FY2025| Metric | Q3 FY2025 | YoY | Q2 FY2025 | QoQ |
|---|---|---|---|---|
| EPS | $1.41 | — | $1.18 | +19.5% |
Guidance
Q3 Insurance Operating Earnings beat prior guidance; 2026 FRE and ANI per share targets reaffirmed with confidence in monetization environment.
Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.
Actuals vs prior guidance
| Metric | Period | Prior guide | Actual | Δ | Result |
|---|---|---|---|---|---|
| Insurance Operating Earnings | Q3 FY2025 | $250+ million per quarter | $305 million | +$55 million above guide | Beat |
Segment performance
Q3 FY2025| Segment | Q3 FY2025 | YoY |
|---|---|---|
| Asset Management - Private Equity | $0.425B | +12.8% |
| Asset Management - Real Assets | $0.426B | +36.6% |
| Asset Management - Credit and Liquid Strategies | $0.338B | +11.0% |
| Insurance Operating Earnings | $0.305B | +27.8% |
Other KPIs
Q3 FY2025| Segment | Q3 FY2025 |
|---|---|
| Assets Under Management (AUM) | $723 billion |
| Fee Paying AUM (FPAUM) | $585 billion |
| New Capital Raised (Q3) | $43 billion |
| New Capital Raised (LTM) | $128 billion |
| Dry Powder (Uncalled Commitments) | $126 billion |
| Fee Related Earnings (FRE) | $1.03 billion (Q3), $3.59 billion (LTM) |
| Total Operating Earnings (TOE) | $1.40 billion (Q3), $4.80 billion (LTM) |
| Adjusted Net Income (ANI) | $1.27 billion (Q3), $4.56 billion (LTM) |
Management tone
Narrative arc (only Q2 prior available, so abbreviated): Q2 reframing of insurance/ABF/wealth as scaled platforms → Q3 dismissive confidence that competitor missteps validate KKR's positioning.
Insurance moved from "fee-AUM multiplier" (Q2) to "multi-segment earnings engine with $1.8B LTM economics" (Q3). Last quarter management quantified $6B of GA third-party capacity translating to $60B+ FPAUM. This quarter they added a dedicated page (page 20) showing $1.8B of LTM insurance-related economics across asset management plus insurance segments, up 16% YoY, with another $200M of annual accrued income not yet recognized. As management put it: "if anything, these figures meaningfully understate the earnings power of owning Global Atlantic." The shift signals that the insurance disclosure framework is being rebuilt so investors stop modeling GA as a $250M/quarter line item and start modeling it as a firm-wide economics engine.
Posture toward industry sentiment shifted from measured optimism to assertive dismissiveness. Q2 commentary characterized institutional discussions as "highly constructive" without taking shots at peers. Q3 brought: "The noise is bad and the facts are good. We will leave it to you to decide which to pay more attention to." Paired with: "some private equity LPs are pulling back from some market participants while we are raising record-sized private equity funds." The shift signals management believes performance dispersion is now wide enough to convert into market-share gains rather than just relative outperformance. Rob Lewin's prepared remarks reinforced this with the specific stat that management fees were up 19% YoY and 7% QoQ — well clear of operating cost growth.
Private credit reframed from "growth opportunity" to "dismiss the systemic risk narrative." Last quarter ABF was positioned as a $6T → $9T addressable market. This quarter the framing pivoted defensively: "$1.7 trillion compared to $145 trillion for the global fixed income market, a very small percentage. So, any suggestion of systemic risk seems ill-informed." The shift signals management is now actively pushing back on emerging market narratives about private credit, suggesting they expect this to be a recurring overhang they need to address rather than a tailwind to promote.
Monetization environment moved from cautiously positive to quantified. Q2 mentioned $800M+ "in line of sight" from pending monetizations as a forward indicator. Q3 reiterated $800M expected over the next two quarters plus quantified $17B of embedded gains firmwide — "the second highest level in our history." The shift signals management is building the realized-carry recovery into the 2026 ANI target with specificity rather than as an upside scenario.
Wealth went from scaled platform (Q2) to momentum-driven 5x growth trajectory (Q3). K-Series AUM at $32B (through Nov 1) vs. $25B at Q2 and $6B two years ago. Capital inflows "80% above" the prior-year Cavalier's comparison. The shift signals K-Series is now compounding quickly enough that management treats it as a primary growth disclosure rather than an emerging-channel update.
Recurring themes management leaned on this quarter:
Risks management surfaced:
Q&A highlights
Glenn Shore · Evercore ISI
Can you wrap up your international perspective on Asia, investor demand for allocating outside the U.S., and quantify how much Asia can add to KKR's overall growth rate and differentiate growth versus competitors?
Investor demand for Asia is increasing markedly across all asset classes. KKR has nine offices with 600+ people on the ground in Asia. Asia AUM has grown from $12B (Asia II fund) to $80B+. Management expects Asia to grow faster than rest of KKR given demographic tailwinds and capital markets development.
Steven Chuback · Wolf Research
What is a reasonable all-in ROE target for the insurance business once various benefits are reflected in the run rate, building on the 18-19% current return?
Management targets taking insurance all-in ROE from high teens to north of 20% over time. Key needle movers are ALTS portfolio maturation generating cash outcomes and third-party capital scaling to $60B+ fee-paying AUM from $6B dry powder. Positioned to benefit from potential spread widening through third-party capital and additional KKR free cash flow deployment.
Bill Katz · TD Callen
What is the normalized ROE level for insurance business and when will it be achieved? What expense-side mitigants exist if $7+ ANI guidance is missed?
Management focuses on $1.8B LTM insurance economics and $200M annual accrued income not yet on P&L (likely beginning 2027-2028). Reiterates $7+ ANI achievable for 2026 dependent on monetization environment, which is currently constructive. $200M accrued is biased to increase materially in 2026. De-emphasizes 2026 TOE target due to cash vs. accrued timing dynamics.
Alex Blovstein · Goldman Sachs
Can you walk through 2026 FRE building blocks including fundraising, management fees, operating leverage, and other components supporting the $450+ billion target?
Management tracking well ahead of $300B+ fundraising target for 2024-2026 (70%+ achieved in 7 of 12 quarters). Capital markets business generating significant outcomes and well-positioned. Fee-related performance revenue scaling with material trajectory in 2026+. Operating costs held well below revenue growth despite substantial scaling.
Answers to last quarter's watch list
What to watch into next quarter
Strategic Holdings disclosure — KKR did not re-anchor this line on the Q3 print after the Q2 -29% YoY drop. Watch whether Q4 brings either a sequential recovery toward the $87M+ quarterly run-rate implied by the 2026 $350M+ target, or a reframing of the disclosure framework similar to what insurance just got on page 20.
2026 FRE/ANI bridge specificity — management reaffirmed $4.50+ FRE and $7.80+ ANI per share. Watch whether the Q4 print or January investor commentary tightens the language from "$4.50+" to a defined band, which would be the strongest signal of conviction.
Insurance accrued income roll-forward — $200M annual run-rate sitting off P&L, "biased to increase materially in 2026." Watch whether Q4 quantifies the 2026 step-up and confirms 2027–2028 as the recognition window.
K-Series momentum — from $6B two years ago to $32B today and growing 28% QoQ. Watch whether the QoQ growth rate sustains above 20% or shows first signs of deceleration, and whether the public PE product launches.
Monetization pipeline conversion — $800M+ flagged for next two quarters from announced deals. Watch the realized-carry print in Q4 against that visibility and whether the $17B embedded gains figure moves up or down.
Asia AUM growth differential — Asia at $80B+ with management stating it will grow faster than the rest of KKR. Watch for a quantified Asia growth rate disclosure (vs. firmwide ~$686B → $723B QoQ this quarter) to validate the differential claim.
Sources
- KKR Q3 FY2025 earnings release — https://www.sec.gov/Archives/edgar/data/1404912/000140491225000040/q325earningsrelease_vf.htm
- KKR Q3 FY2025 earnings call commentary
- KKR Q2 FY2025 brief (Tapebrief, 2025-07-31)
Get the next brief, free.
We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.
This is not investment advice.